On September 9th, Professor Scheffler was quoted in an article in California Healthline surrounding the upcoming Sutter Health trial on September 23rd. Sutter has been accused of infringing on antitrust laws in the state by decreasing competition and ultimately overcharging patients. Scheffler was quoted saying, “One of the reasons we have such a big problem [with consolidation] is that they’ve done very little. Enforcement has been very weak.”
To read the full article, click here.